AIM Therapeutics is an early stage pharmaceutical company focused on developing breakthrough medical treatments for inflammatory and immune disorders including asthma, spinal cord injury, and restenosis.
Our mission is to provide hope and create a better future for people suffering from debilitating inflammatory diseases. We have an unrelenting passion for what we do, and we are proud of the progress that we’re making. We hope that while clicking through our web site you sense the excitement and pride with which we approach our work. We invite you to visit our web site frequently to follow our developments, and we encourage you to contact us directly with any ideas or questions you may have.
Toronto, Ontario - September 29, 2008 – AIM Therapeutics Inc., announces that Dr. Richard Timmer, President and CEO, will be presenting at BioContact Québec, Fairmont Le Château Frontenac, Québec, on Wednesday, October 1, 2008.
AIM Therapeutics has continued to make steady progress throughout the second quarter of 2008.